NEXN Gene Cardiomyopathy dilated type 1CC Genetic Test
At DNA Labs UAE, we offer the NEXN Gene Cardiomyopathy dilated type 1CC Genetic Test. This test is designed to analyze the NEXN gene for mutations associated with dilated cardiomyopathy (DCM), specifically the dilated type 1CC subtype.
Test Details
The NEXN Gene Cardiomyopathy, dilated type 1CC NGS Genetic Test is a genetic test that uses Next-Generation Sequencing (NGS) technology to analyze the NEXN gene for any disease-causing mutations. This test is specifically focused on identifying mutations associated with dilated cardiomyopathy.
Cardiomyopathy refers to a group of diseases that affect the heart muscle, leading to abnormal heart function. Dilated cardiomyopathy, in particular, is characterized by the enlargement and weakened pumping ability of the heart chambers.
The NEXN gene provides instructions for producing a protein called Nexilin, which plays a crucial role in maintaining the structure and function of heart muscle cells. Mutations in the NEXN gene can disrupt the normal functioning of Nexilin, leading to the development of dilated cardiomyopathy.
Test Components and Price
The NEXN Gene Cardiomyopathy dilated type 1CC Genetic Test is priced at 4400.0 AED. The test can be conducted using a blood sample, extracted DNA, or one drop of blood on an FTA Card.
Report Delivery and Method
The report for the NEXN Gene Cardiomyopathy dilated type 1CC Genetic Test is typically delivered within 3 to 4 weeks. The test utilizes NGS technology for accurate and efficient analysis of the NEXN gene.
Test Type and Doctor
The NEXN Gene Cardiomyopathy dilated type 1CC Genetic Test falls under the category of Cardiovascular Pneumology Disorders. It is recommended to consult a cardiologist for this specific genetic test.
Test Department and Pre Test Information
The NEXN Gene Cardiomyopathy dilated type 1CC Genetic Test is conducted in the Genetics department. It is essential to provide the clinical history of the patient who is undergoing the test, along with a genetic counseling session to draw a pedigree chart of family members affected by NEXN Gene Cardiomyopathy.
Importance of the Test
The NEXN Gene Cardiomyopathy dilated type 1CC Genetic Test helps identify individuals who have an increased risk of developing dilated cardiomyopathy due to NEXN gene mutations. Understanding the genetic cause of dilated cardiomyopathy is crucial for its diagnosis, management, and treatment. Additionally, it provides valuable information for family members who may be at risk of inheriting the mutation.
It is important to note that this genetic test should be performed in a clinical setting, and the results should be interpreted by a healthcare professional with expertise in genetics and cardiology.
Test Name | NEXN Gene Cardiomyopathy dilated type 1CC Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Cardiovascular Pneumology Disorders |
Doctor | Cardiologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for NEXN Gene Cardiomyopathy, dilated type 1CC NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with NEXN Gene Cardiomyopathy, dilated type 1CC NGS Genetic DNA Test gene NEXN |
Test Details |
NEXN Gene Cardiomyopathy, dilated type 1CC NGS Genetic Test is a genetic test that analyzes the NEXN gene for mutations associated with dilated cardiomyopathy (DCM), specifically the dilated type 1CC subtype. Cardiomyopathy refers to a group of diseases that affect the heart muscle, leading to abnormal heart function. Dilated cardiomyopathy is characterized by the enlargement and weakened pumping ability of the heart chambers. The NEXN gene provides instructions for producing a protein called Nexilin, which is involved in maintaining the structure and function of heart muscle cells. Mutations in the NEXN gene can disrupt the normal functioning of Nexilin, leading to the development of dilated cardiomyopathy. The NEXN Gene Cardiomyopathy, dilated type 1CC NGS Genetic Test uses Next-Generation Sequencing (NGS) technology to analyze the NEXN gene for any disease-causing mutations. This test can help identify individuals who have an increased risk of developing dilated cardiomyopathy due to NEXN gene mutations. Knowing the genetic cause of dilated cardiomyopathy can help in the diagnosis, management, and treatment of the condition. It can also provide valuable information for family members who may be at risk of inheriting the mutation. It is important to note that this genetic test is typically performed in a clinical setting, and the results should be interpreted by a healthcare professional with expertise in genetics and cardiology. |